Intuitive Surgical, Inc. $ISRG Shares Acquired by Navera Investment Management Ltd.

Navera Investment Management Ltd. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.7% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 610,070 shares of the medical equipment provider’s stock after buying an additional 78,252 shares during the period. Intuitive Surgical comprises about 5.2% of Navera Investment Management Ltd.’s portfolio, making the stock its 9th biggest holding. Navera Investment Management Ltd.’s holdings in Intuitive Surgical were worth $272,832,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Howland Capital Management LLC increased its holdings in shares of Intuitive Surgical by 1.3% during the 3rd quarter. Howland Capital Management LLC now owns 3,781 shares of the medical equipment provider’s stock valued at $1,691,000 after acquiring an additional 47 shares during the last quarter. NBT Bank N A NY boosted its position in Intuitive Surgical by 1.5% during the third quarter. NBT Bank N A NY now owns 3,472 shares of the medical equipment provider’s stock worth $1,553,000 after purchasing an additional 50 shares during the period. Ritholtz Wealth Management grew its holdings in Intuitive Surgical by 0.8% during the third quarter. Ritholtz Wealth Management now owns 5,676 shares of the medical equipment provider’s stock valued at $2,539,000 after purchasing an additional 43 shares during the last quarter. Davis Rea LTD. bought a new position in shares of Intuitive Surgical in the third quarter valued at approximately $6,920,000. Finally, Dillon & Associates Inc. lifted its stake in shares of Intuitive Surgical by 5.3% in the third quarter. Dillon & Associates Inc. now owns 28,474 shares of the medical equipment provider’s stock worth $12,728,000 after buying an additional 1,436 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Phase‑3 update on IS‑001 imaging drug — Intuitive advanced its Phase‑3 study aimed at reducing ureter injuries in robotic colorectal surgery, a safety-focused adjoint that could expand the company’s addressable offering and reinforce surgical‑safety differentiation. Intuitive Surgical Advances Phase 3 Imaging Drug
• Positive Sentiment: daVinci systems demand highlighted — Company commentary and industry coverage say system performance “exceeded expectations” and Intuitive is pushing for more placements, supporting procedure growth and recurring consumable revenue. Intuitive says daVinci systems ‘exceeded expectations,’ it wants more
• Positive Sentiment: Analyst support remains — At least some brokers (e.g., Bernstein) have reiterated buy ratings, signaling continued sell‑side conviction in ISRG’s long‑term growth profile despite near‑term noise. Bernstein Sticks to Their Buy Rating for Intuitive Surgical (ISRG)
• Positive Sentiment: Investor take: “buying the dip” narratives are emerging — Several bullish commentaries argue the pullback is an entry point given Intuitive’s wide moat, recurring consumables and procedure tailwinds. Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder
• Neutral Sentiment: Analysts preparing for Q4 — Preview pieces outline the metrics (procedures, system placements, ASPs, margin drivers) that will matter when full Q4 results and guidance details arrive; these previews can amplify volatility around the print. Intuitive Surgical (ISRG) Q4 Earnings on the Horizon
• Neutral Sentiment: Brokerage commentary roundup — Coverage pieces remind investors that analyst ratings and model changes often move shares; they’re useful context but not a definitive signal by themselves. Brokers Suggest Investing in Intuitive Surgical (ISRG)
• Negative Sentiment: Preliminary Q4 revenue reaction — Although Intuitive reported strong preliminary Q4 and full‑year revenue growth, shares dipped as investors parsed procedure trends, margin dynamics and what management said about demand cadence. That disconnect between a beat and stock action is a key reason for the pullback. Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results
• Negative Sentiment: Softer 2026 outlook flagged — Company commentary and reporting point to a softer 2026 outlook that trimmed forward expectations, which is the primary negative driver behind today’s weakness. Intuitive Surgical Sets Softer 2026 Outlook
• Negative Sentiment: Market reaction analysis — Coverage asking “why did shares dive?” notes investors punished the stock for guidance/trajectory concerns despite the beat, illustrating that forward commentary and margin clarity matter more than one‑time beats. Intuitive Surgical Crushed Fourth-Quarter Forecasts. So Why Did Shares Dive?

Intuitive Surgical Stock Down 1.2%

NASDAQ ISRG opened at $535.00 on Friday. The stock has a market cap of $191.79 billion, a P/E ratio of 70.77, a PEG ratio of 4.35 and a beta of 1.67. The company’s 50-day simple moving average is $566.32 and its 200 day simple moving average is $512.06. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the business earned $1.84 earnings per share. The company’s quarterly revenue was up 22.9% on a year-over-year basis. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 22,806 shares of the company’s stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the sale, the insider directly owned 2,694 shares of the company’s stock, valued at approximately $1,537,977.66. This represents a 89.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Craig H. Barratt sold 750 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $435,000.00. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 114,007 shares of company stock valued at $63,533,844. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Truist Financial raised their target price on shares of Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a research note on Thursday, December 18th. HSBC raised their price target on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Sanford C. Bernstein reissued an “outperform” rating and set a $740.00 price objective (up previously from $700.00) on shares of Intuitive Surgical in a research report on Friday, January 9th. Rothschild & Co Redburn increased their target price on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Finally, Royal Bank Of Canada upped their price target on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $622.17.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.